Shanghai Green Valley launches brown algae-based Alzheimer’s drug

Bloomberg News reports that a newly approved Chinese drug for Alzheimer’s will start clinical trials in the U.S. and Europe this year as the country’s first novel therapy for the incurable disease seeks global legitimacy…

Read More